Vergent Bioscience, Inc., 2025-10-20
An SEC Form D private-offering notice from Minneapolis, MN, a $31,957,273 filer-stated offering target in Biotech. Filed 2025-10-20. The source filing is one click away. For companies that filed this week, open the live feed.
What this filing says
Clinical-stage biotech developing tumor-targeted fluorescent imaging agents to help surgeons visualize and remove cancer tissue during minimally invasive and robotic-assisted surgery, starting with lung cancer.
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.
Other Form D filings from the same week
each with its own page and its own EDGAR source- VentureMed Group, Inc., 2025-10-31, $49.2M, Plymouth, MN
- MOAT BIOTECHNOLOGY Corp, 2025-10-20, $15.6M, Oklahoma City, OK
- EarthOptics, Inc., 2025-10-28, $51.3M, Minneapolis, MN
- Pacific Diabetes Technologies, Inc., 2025-10-20, $3.5M, Portland, OR
- AGITATED SOLUTIONS, INC., 2025-10-22, $13.7M, Saint Paul, MN
- inSoma Bio, Inc., 2025-10-20, $4M, Durham, NC
The Monday digest, free
A summary of who raised money last week: the ones worth a call first, then every company that filed, by state and sector. One email, Monday mornings. No spam, unsubscribe anytime.
By subscribing you agree to our Terms and Privacy Policy.